The regulator flagged several shortcomings in the sale, including failures related to product suitability, solicitation, disclosures and the insurer’s internal controls.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.